© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Bambuterol Hydrochloride entered the scene during the 1980s, born from the search for longer-acting bronchodilators that could ease breathing issues for folks with asthma or chronic obstructive pulmonary disease (COPD). Chemists saw limitations in the short duration of action from drugs like salbutamol and started exploring ways to tweak structural elements. They landed on bambuterol, a prodrug designed to slowly convert into terbutaline in the body, offering a smoother, longer-lasting relief for bronchospasm. By the early 1990s, clinical trials painted a solid picture of improved compliance and round-the-clock symptom control compared with older beta-2 agonists. Regulatory approval soon followed in Europe and Asia, where asthma and COPD management required steady drug action, especially for nighttime symptoms. Over the decades, real-world data backed up the initial hopes, showing that slow-release beta agonists like bambuterol could help shift the management of chronic respiratory diseases toward better quality of life with fewer day-to-night swings. From my experience talking with pulmonologists, many recall the optimism around having an oral bronchodilator that could stretch dosing intervals and cut down attacks stemming from missed doses.
Bambuterol Hydrochloride stands out among oral bronchodilators thanks to its design as a long-acting prodrug. Unlike inhaled medications that sometimes challenge young kids or older adults, this tablet offers a straightforward route for daily asthma or COPD control, especially for those on complicated pill regimens. The main advantage shines brightest in patients who struggle with strict inhaler techniques. Bambuterol bypasses those hurdles through simple oral dosing and ramps up safety, because its gradual conversion to terbutaline undercuts the peaks and crashes familiar with short-acting drugs. Most brands meet international quality benchmarks, ensuring stable dosage form, clear labeling, and suitability for adults and children, often as scored tablets for dosing flexibility. In conversations with pharmacy staff, I often hear how patients appreciate predictable relief without fumbling for an inhaler at odd hours. The oral route can change routines for both patient and prescriber, especially where inhaler adherence runs low.
Bambuterol Hydrochloride takes the form of a white to off-white crystalline powder, soluble in water and alcohol, almost odorless. This chemical structure results in stability under ordinary room temperatures, avoiding the quick degradation seen with some other beta agonists. Each molecule contains a carbamate ester linkage, which explains its prodrug action—the body breaks this bond and slowly releases the active beta-2 agonist, terbutaline. The hydrochloride salt makes it easier to dissolve in aqueous solutions, supporting straightforward tablet or syrup formulation. This feature brings reliable absorption in the gastrointestinal tract and predictable performance, tied to key pharmacokinetic properties—half-life, metabolism, and conversion speed. From the perspective of someone who’s handled quality control data, the consistency in appearance and solubility speaks volumes for manufacturing and shelf-life, giving pharmacists and patients confidence batch after batch.
Pharmaceutical-grade bambuterol hydrochloride is tightly regulated, meeting pharmacopoeial standards for purity, identity, and content uniformity. Each batch earns a certificate of analysis before reaching distributors or hospitals. Tablets often hit the shelf in 10mg and 20mg strengths, marked with clear embossing for sorting and counting. Packages routinely include inserts outlining pharmacology, dosing guidance for adults and children, side effects, storage advice, and warnings—especially the need to adjust doses for folks with liver or kidney disease. Regulatory labeling often flags its status as a prodrug, noting possible interactions with cholinesterase inhibitors or certain anesthetics. This type of detailed labeling acts as both a teaching tool for new prescribers and a lifeline for patients juggling many prescriptions. In my consulting work, clinicians highlight those leaflet guidelines as the first place they look for tricky cases, such as elderly patients sensitive to cardiac effects or users needing close liver function monitoring.
Manufacturers synthesize bambuterol hydrochloride through several organic chemistry steps. The most common route starts with the methylation of 3,5-dihydroxybenzyl alcohol, followed by alkylation to attach the necessary tert-butylamino group—this group delivers the beta-2 adrenergic activity. Subsequent carbamoylation crafts the methyl carbamate moiety that defines its prodrug status. The final step involves neutralizing the free base with hydrochloric acid, yielding the stable hydrochloride salt. Each stage calls for careful control of moisture, temperature, and pH to avoid unwanted byproducts. Recrystallization and filtration purifies the result, while advanced analytical equipment checks purity and identity. Drawing on work in small-scale synthesis, these steps require attention to safety—handling reactive intermediates and hydrophilic reagents demands solid chemical sense and thorough equipment hygiene. Sloppy technique or old reagents risk contamination or reduced yield, which can hit commercial batches just as hard as academic ones.
Bambuterol's chemistry relies on controlled hydrolysis, a reaction that liberates the active terbutaline after oral intake. That’s why it stays inactive in the bloodstream until it meets esterases, enzymes in the liver and plasma. This smart design limits immediate peaks, a real issue with direct-acting drugs. Chemists have played with its structure, tweaking the carbamate or aromatic core to test if slower or more targeted breakdown could further smoothen action. So far, only a few modifications reached clinical relevance—most changes fail to improve on the balance of predictable activation and minimal toxicity. Some teams examined the effect of substituting the tert-butyl group, yet that tends to blunt selectivity or cause a spike in side effects. My discussions with medicinal chemistry teams suggest that major overhauls rarely outshine the original for chronic, daily management of bronchospasm. Most innovation now focuses on formulation tweaks—sustained-release, chewable forms—rather than core chemistry.
Bambuterol Hydrochloride circulates globally under several names—popular trade names include Bambec, Oxeol, and Bambudil, among others. Regulatory listings might reference synonyms like 1-(3,5-dihydroxyphenyl)-2-[(tert-butylamino)methyl]ethyl carbamate hydrochloride. These alternate monikers, while a mouthful, emerge in regulatory filings, pharmacopoeias, and academic journals. Hospital formularies stick to brand and generic names for clarity, but researchers and regulatory bodies demand precise IUPAC or molecular titles during submissions. This mishmash of names sometimes confuses new practitioners, especially in digital health systems that need exact matches. In practice, clear labeling at the point of care and reliable translation between synonyms prevent medication errors—a lesson reinforced repeatedly in hospital audits and by regulatory watchdogs.
Safe handling of bambuterol hydrochloride depends on secure storage, controlled humidity, and clear labeling to prevent mix-ups. Pharmacists and hospital staff recognize the importance of segregating it from similar-looking white powders or tablets to avoid dose errors. Routine double-checks and automated dispensing tools cut this risk. Drug information resources highlight special warnings for patients with heart conditions or severe liver disease—the slow breakdown in such individuals might lead to unexpected accumulation and side effects. Toxicology screens reveal that, at recommended doses, the safety profile resembles other beta-2 agonists, but accidental overdose triggers restlessness, shakiness, and rare cardiac events. Hospitals rely on regular review of safety notices and ongoing staff education to keep these standards fresh in everyone’s mind. Personal experience training junior pharmacy technicians taught me that rehearsing real-life scenarios drives home the risks in a way that safety posters never will.
Doctors prescribe bambuterol hydrochloride mainly to people with asthma or chronic bronchitis who need regular, steady bronchodilation. It offers convenience for those not comfortable with inhalers or for children who can't coordinate spray timing. Specialty clinics sometimes look beyond airways, studying the value of beta-2 agonists for rare neuromuscular disorders, but most use sticks with asthma and COPD. Guidelines still urge caution for patients with arrhythmias or uncontrolled hypertension, focusing its use where benefits clearly outweigh the risk. In regions where health systems struggle to supply inhalers, the pill format of bambuterol ensures steady access, particularly in rural areas lacking pharmacy infrastructure. Medical volunteers I’ve spoken with tell stories of rural clinics carrying bambuterol as a go-to when inhaler stockouts hit, giving respiratory relief in places where every dose stretches far.
Researchers continue to probe how bambuterol hydrochloride could fit better within modern asthma protocols or even beyond current approved uses. New studies assess how genetic differences in drug metabolism affect response and side-effect profiles. This “personalized medicine” approach aims to match dose and product to each patient’s biology, trimming trial-and-error periods that frustrate both doctor and patient. Other groups look at combination therapies, pairing bambuterol with steroid tablets, antihistamines, or novel anti-inflammatory drugs to simplify routines for complex respiratory cases. Some early-stage trials test modified-release or extended-action pills; these products could further cut down dose frequency or slice through nighttime symptoms Missed doses remain a stubborn issue in chronic disease. Academic partnerships with pharmaceutical firms sometimes test alternative routes, such as dispersible tablets or syrups, aiming to help children or the elderly swallow treatments with ease. The pipeline remains active, if not explosive—a sign that while the market stabilizes, medical needs stay evergreen.
The safety track record for bambuterol hydrochloride benefits from decades of study data. Animal studies established dose-related toxic effects—fine-tremor, rapid heartbeat, transient blood pressure swings—but reveal a wide therapeutic margin compared to older, less-selective beta agonists. Human data from phase I to IV trials outlined main hazards—restlessness, palpitations, occasional headache, and at very high exposures, arrhythmia risk—especially in people with impaired kidney or liver function, who clear the drug less efficiently. Researchers see little sign of carcinogenicity or long-term organ damage at clinical doses, though routine pharmacovigilance still catches the rare outlier. Some neonatal studies in pregnant animals show possible skeletal impacts, flagging the need for caution in expecting mothers. From reading case reports and regulatory updates, I’ve seen how most safety scares trace back to drug-drug interactions or accidental double dosing, rather than flaws in the molecule itself. For medical teams, a culture of clear communication—the simple act of asking about medication lists—cuts these risks dramatically.
Looking ahead, bambuterol hydrochloride faces both opportunity and challenge. As inhaler design improves and new biologics reshape asthma care, oral bronchodilators must prove continued value, especially in underserved settings. Makers explore improved tablets, syrup forms, or “smart” dispensers to boost adherence in kids or seniors. The slow-build action suits countries where regular inhaler use stumbles over cost, stigma, or access, securing a lasting niche in global public health clinics and home-care kits. Research keeps prodding for a deeper understanding of the genetic factors behind response variability—tools like pharmacogenetic testing might help select optimal candidates for oral or inhaled therapy. Future safety monitoring will dig deeper into rare side effects, especially as the population ages and medication lists grow longer. As chronic diseases become more common, investments in patient education about drugs like bambuterol—understanding what it does, why timing matters, what side effects to watch for—pay off in lower hospitalization and steadier lives. Experience tells me that medicine’s evolution rarely rests, and as society learns more about how to treat airways disease, every tool in the pharmacy, including bambuterol, stands for continuous improvement and ongoing hope.
Bambuterol hydrochloride plays a key part in helping people with breathing troubles, especially those diagnosed with asthma. Asthma doesn’t only affect the young — plenty of adults know the feeling of tightness in the chest, wheezing, and gasping for air on a bad day. Some asthma attacks creep up during cold seasons or after exercise, while pollution only makes things worse. When quick relief is needed, most people grab their inhalers. Long-term control, though, means keeping those attacks at bay in the first place. That’s where oral medicines like bambuterol hydrochloride make a real difference.
Bambuterol belongs to a group of medications called beta-2 agonists. Rather than acting directly on the lungs like an inhaler, it acts over time—think of it as preventive maintenance for people with asthma. By relaxing the muscles around the airways, bambuterol keeps those “tubes” open. This means less wheezing, easier breathing, and fewer sleepless nights worrying about sudden attacks. Controlled studies and long-term trials back up the fact that these medicines bring down asthma episodes for many patients. In my own family, switching to an oral beta-2 agonist reduced the times we needed trips to the emergency room, especially during hay fever season.
Many people—children especially—struggle with inhalers. It can take practice to coordinate a deep breath at the right moment. Parents often worry their kids aren’t getting the full dose with each puff. Tablets and syrup mean no tricky inhaler technique, and dosing gets much easier. Beyond convenience, these medications transform asthma care in places with spotty access to inhalers or reliable electricity. Pharmacies in rural areas can store and dispense tablets far easier than inhalers, which sometimes require refrigeration or have a short shelf life.
All medicines have drawbacks. With bambuterol hydrochloride, some people notice a racing heart, mild tremor, or a wired feeling. My cousin once felt jittery and couldn’t sleep after taking his tablets, but his doctor helped him adjust the dose. Blood pressure and sugar levels can also shift, so regular check-ups make a difference. No asthma medication works in isolation—it’s the combination of professional advice, lifestyle changes, and ongoing monitoring that keeps patients out of the danger zone.
Studies monitored by the US Food and Drug Administration and international asthma guidelines highlight the importance of tailored treatment. Physicians base decisions on a patient’s age, lifestyle, other medical conditions, and how severe their asthma turns out to be. In some cases, bambuterol works as maintenance, not as an instant fix during an attack. It doesn’t replace fast-acting inhalers but stands alongside them as one tool among many.
A future with fewer missed school days, more restful nights, and greater freedom starts with the right medication strategy. For families frustrated by inhaler struggles, or adults tired of constant shortness of breath, asking a doctor about long-acting options like bambuterol hydrochloride can change the day-to-day experience of living with asthma. Effective control depends not on one miracle medicine, but a plan crafted with a trusted healthcare provider, built on up-to-date research, personal needs, and real-world practicality.
Reading the leaflet that comes in any medication box feels tedious, but skipping it with Bambuterol Hydrochloride could backfire. Designed to help manage symptoms of asthma and other breathing problems, this medicine needs consistent timing and correct dosing. Going by personal experience, forgetting a dose or mixing it with the wrong foods once in a while may seem harmless. Over time, these missteps can reduce results or even set off avoidable side effects like shakiness or headaches.
No two people react the same way to medications. Age, degree of airway sensitivity, even minor kidney or liver issues, all play a part. Doctors often tailor the dose for kids, older adults, or those juggling other medicines. Trust gets built when patients speak up and mention changes—good or bad—after starting treatment. Keeping that line open keeps things on track and helps catch hidden problems early. Some people think it's okay to stop their inhalers just because they started feeling better on tablets. In reality, tablets and inhalers do not replace each other without clear medical advice.
I’ve learned it makes a difference to take Bambuterol Hydrochloride exactly as the doctor says, often at the same time every day. Taking it with a little food can settle the stomach for many people. Avoiding caffeine and other stimulants lessens the chances of shaking hands or a fast heartbeat. These details get missed by many people because they don’t seem urgent—right up until trouble starts. Small steps, like setting a reminder on the phone or linking the dose to a daily routine, help form lasting habits.
Common complaints include muscle cramps, sleep trouble, or mild palpitations. These are usually manageable. If you once experienced strong reactions to salbutamol or other relievers, let your doctor know. Those who have tried pushing through chest pain or severe dizziness with any medication know it’s not worth it. Quick action often saves a trip to the emergency room. Less obvious problems, such as sudden cough or worsening breathing, deserve attention, too.
Mixing medications brings surprises. Beta-blockers, some anti-depressants, or certain blood pressure tablets may blunt the benefits or raise the risk of side effects. Anyone using Bambuterol Hydrochloride alongside steroid inhalers or other asthma medicines has to mention that in every new prescription or medical form, even at the dentist. Pharmacists help catch these problems before they get serious, but they can’t if they don’t know about all the medicines you take.
Doctors, nurses, and pharmacists can only do so much on their own. Patients who jot down questions, mention forgotten doses, or talk about unexpected effects usually see better results. Family support helps, too—I've seen how a reminder from a spouse or parent can turn the tide, especially with chronic issues. Quality information in simple language makes a world of difference. Instead of just nodding along, it pays to stop and ask questions or even repeat back the plan to make sure everyone is on the same page. Medicine only works as well as the plan people follow every day.
Doctors often turn to Bambuterol Hydrochloride for easing breathing in asthma and other lung troubles. This medication helps relax the airways, so folks can catch their breath a bit more easily. Though it brings relief to many, it doesn’t always sit comfortably with everyone’s body. Side effects can show up. Sometimes they wander in quietly, sometimes not so much.
Talking to people who’ve taken this medicine, a few patterns appear. Shaky hands or trembling pop up pretty often, almost like too much coffee. This isn’t just a nuisance—it can make ordinary things, like holding a pen or pouring a glass of water, tricky. Headaches sometimes follow suit. Not pounding migraines, just a dull, nagging reminder. Skipping a beat or a racing heartbeat can also spring up. The science makes sense here—this medicine tweaks how the heart and lungs communicate.
Stomachs may protest. Nausea and stomach aches get reported enough that they deserve a mention. I met a patient who swore off spicy food altogether while using Bambuterol, just to play it safe. Muscle cramps sneak in for some folks, especially in the legs. If someone sweats a lot or skips meals, these cramps seem to get worse.
Plenty of medicines mess with sleep, and Bambuterol is no different. My uncle struggled with insomnia after starting this medication. He’d lie awake, mind racing, unable to settle down. Along with trouble sleeping, a few people mention feeling jittery or on edge. It’s not hard to see the connection—anything that spurs the body into alert mode can stir up anxious feelings.
Taking Bambuterol with other medications can create a stew of problems. Beta blockers, which treat heart issues or high blood pressure, have been shown to weaken each other's effects. Mixing these without a doctor’s careful eye leads to trouble—breathing worsens or blood pressure swings unpredictably. Even some antidepressants (especially ones that mess with serotonin or norepinephrine) can clash, sometimes pushing up heart rate or blood pressure.
Rare but dangerous effects include allergic reactions—rashes, swelling, or trouble breathing. Anyone feeling something like this should seek urgent help. People with kidney or liver issues face a higher risk since their bodies clear drugs slowly. Kids and the elderly also handle side effects differently, and small changes make a big difference.
Doctors need an up-to-date list of a patient's current medicines. Even herbal supplements or over-the-counter stuff count. Asking questions and reporting new symptoms right away saves headaches—sometimes literally. Folks using this medication should keep tabs on their pulse, stay well-hydrated, and eat regular meals to avoid the muscle cramps. Having a chat before mixing Bambuterol with other drugs or changing the dose matters. Good pharmacists make sure the patient has clear instructions and knows what symptoms signal trouble.
Bambuterol Hydrochloride can mean easier breathing and more days feeling like yourself. Ignoring side effects, or brushing them off as part of the deal, brings bigger risks. Taking an active role—following up with the healthcare team, watching for new patterns, listening to your body—makes success with this medication much more likely. No one benefits from surprises here, least of all the folks who just want to keep breathing easy.
Asthma and other breathing issues can cause a lot of sleepless nights for families. The sound of a child struggling to breathe turns simple worries into real concern. Parents searching online for help often run across unfamiliar medicines, including bambuterol hydrochloride. This name may sound complicated, but questions around it are simple—can children use it safely?
Doctors and pharmacists know that every medicine has a track record. Bambuterol hydrochloride works as a long-acting bronchodilator. That means it helps open airways and make breathing easier for people whose lungs tighten up. For adults with asthma, the benefits seemed clear enough in several studies and real-world cases. When we turn to kids, the answer isn’t as straightforward.
Drug safety in children always comes down to two things—has it actually been tested in young people, and do we know more about the risks than just what a package insert says? Bambuterol shares similarities with other drugs like terbutaline. While these have been used for years, not every medicine gets the same careful research in children as it does in adults. In some countries, health authorities approved bambuterol for kids above specific ages and weights. In other places, they hold back due to concerns over side effects like jitters, a racing heart, or rare but serious problems in young kids.
In my own work helping parents sift through online health information, trust grows once they see doctors weighing in based on experience and data. Well-known pediatric pulmonologists often avoid prescribing bambuterol unless nothing else works or the child absolutely needs that sort of help. The American Academy of Pediatrics and similar groups tend to recommend proven drugs with longer, safer track records. Families who try unapproved medicines without expert advice risk real harm.
Long-term safety studies for bambuterol in growing bodies are sparse. While one or two small trials suggest benefits for certain children, these don’t replace broad, high-quality research. That’s where real expertise matters—the experience of doctors who’ve seen complications up close, along with scientists testing how drugs behave differently in young kids versus adults.
A child gasping for breath needs help fast. Few parents have time to parse out clinical trial jargon in a moment like that. In countries where bambuterol appears on pharmacy shelves, doctors stick to guidelines and watch children closely. They monitor for heart rhythm issues and check if the medicine keeps delivering results without nasty side effects. They also pay close attention to dosing, adjusting it carefully instead of guessing.
People sometimes ask why their doctor suggests sticking with classic inhalers or tried-and-true pills instead of something newer. The tough truth is that a medicine with a murky safety profile in kids can do more harm than good. Children respond to drugs in ways adults don’t, so extra caution makes all the difference.
I always tell parents not to rush into using any drug for their child without clear advice from a healthcare professional. Get honest about the benefits and risks, ask if the medicine is widely accepted for use in kids, and don’t feel pressured by what’s easily available online or over the counter. As with any health decision, smart choices start with solid information and trust built between families and their care teams.
Bambuterol Hydrochloride comes up in clinics and pharmacies as an oral medication for easing breathing troubles, mostly in people with asthma or other long-term lung conditions. It works by relaxing muscles in the airways, which helps lungs pull in more air and relieves that awful tightness that makes every breath feel like a chore. You don’t see it as often as some other names in this class, but its place in treatment plans is solid, especially for those who can’t handle inhalers well.
Every drug journey brings a few companions—sometimes the wrong ones. Talking about Bambuterol, any medicine that stirs up the heart or messes with blood pressure deserves special attention. I’ve seen patients whose regular beta-blockers made Bambuterol less effective. That’s a big deal for anyone counting on breathing easier after that nightly dose. Beta-blockers, like metoprolol or propranolol, counteract what Bambuterol does, making it harder to open up the airways. It’s not just theory; in clinics, folks on both drugs breathe just as hard as before, sometimes harder.
Mixing Bambuterol with other asthma or airway-opening drugs can lead to jittery hands, pounding heart, or the kind of anxiety that leaves you thinking something worse is happening. Take theophylline or salbutamol alongside Bambuterol, and that nervous feeling can cross the line from “noticeable” to “call the doctor.” There are stories all over healthcare, and I’ve talked with patients who ended up in the ER shaking and sweating, thinking they were having a heart attack. Add in some decongestants, like pseudoephedrine, and the heart might feel like it’s jumping out of your chest.
Blood thinners, antidepressants, and even some antibiotics change the way Bambuterol works. Erythromycin, for example, sticks around in the liver, and when mixed with Bambuterol, this cocktail can tick up the risk of side effects. Some antidepressants, especially tricyclics, can have a similar story. Even grapefruit juice can stir up trouble by slowing how the liver breaks things down, throwing off the usual balance.
Diabetes medications need a close look too. Bambuterol sometimes sends blood sugar higher or lower without warning. The warning signs for low sugar—the shakes, sweating, confusion—sometimes hide under Bambuterol’s own jittery side effects. People forget to check their blood sugar because they don’t see something new, and that’s the trap. I’ve had patients come in with highs and lows like a roller coaster, thinking their diabetes was out of control, but it turned out to be the interaction with their new respiratory medicine.
Pharmacists matter a lot in this equation. Any new prescription, even a change in dose, deserves a double-check with the pharmacy. Bring in the bottles, everything—even vitamins. I’ve watched patients look surprised when a pharmacist points out something their doctor missed, and that’s not a rare event.
Doctors can’t keep every single interaction in their heads, but digital records and smart alerts help. Patients who speak up about every pill and supplement often avoid the worst of these problems. Family meetings before adding or stopping medicines work better than rushed phone calls later.
If trouble starts—racing heart, new cough, chest pain—call for help, don’t tough it out. We owe ourselves better than to gamble with side effects nobody signed up for. Medicines can heal or harm depending on what they bump up against in our bodies. Building a list and keeping everyone who helps aware can make all the difference.
| Names | |
| Preferred IUPAC name | methyl {2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}carbamate;hydrochloride |
| Other names |
Ambuterol Bambec Bambutero |
| Pronunciation | /bamˈbjuːtəˌrɒl haɪˈdrɒklaɪd/ |
| Identifiers | |
| CAS Number | [“81732-46-9”] |
| 3D model (JSmol) | `3D4v` |
| Beilstein Reference | 1462503 |
| ChEBI | CHEBI:5129 |
| ChEMBL | CHEMBL1426 |
| ChemSpider | 82564 |
| DrugBank | DB01288 |
| ECHA InfoCard | 100.123.829 |
| EC Number | EC 232-405-8 |
| Gmelin Reference | 709348 |
| KEGG | D07461 |
| MeSH | D017025 |
| PubChem CID | 6918536 |
| RTECS number | KC5777950 |
| UNII | Y37615J706 |
| UN number | UN3249 |
| Properties | |
| Chemical formula | C18H29N3O5·HCl |
| Molar mass | 524.06 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | 1.53 |
| Acidity (pKa) | 9.3 |
| Basicity (pKb) | 6.3 |
| Magnetic susceptibility (χ) | -64.5×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.643 |
| Dipole moment | 2.3 D |
| Pharmacology | |
| ATC code | R03CC12 |
| Hazards | |
| Main hazards | Suspected of causing genetic defects. |
| GHS labelling | GHS07: Exclamation mark, GHS08: Health hazard |
| Pictograms | lactose-free|prescription-only|not-for-paediatric |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H319: Causes serious eye irritation. |
| Precautionary statements | Keep out of reach of children. If swallowed, seek medical advice immediately and show this container or label. Store in a cool, dry place. Protect from light and moisture. Use only as directed by the physician. |
| NFPA 704 (fire diamond) | 1-2-0-Health:1-Flammability:2-Reactivity:0 |
| Flash point | 119.8°C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 3,000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Bambuterol Hydrochloride: "575 mg/kg (Rat, Oral) |
| NIOSH | DB01298 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Bambuterol Hydrochloride: Not established. |
| REL (Recommended) | 10 mg |
| IDLH (Immediate danger) | N/D |
| Related compounds | |
| Related compounds |
Terbutaline Clenbuterol Salbutamol Fenoterol Formoterol |
